The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Lung Cancer
Open accessAbstract
The Molecular Origins of Cancer series continues with this review of molecular and genetic mechanisms of lung cancer. The authors review genetic susceptibility to lung cancer and four genes of importance in the evolution of the disease: EGFR, KRAS, the PI3K–Akt–mTOR complex, and TITF1. They also discuss gene profiling and protein profiling, with emphasis on the clinical value of these methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Genomic signatures to guide the use of chemotherapeutics
Potti, A., Dressman, H. K., Bild, A., Riedel, R. F., Chan, G., Sayer, R., Cragun, J., Cottrill, H., Kelley, M. J., Petersen, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1491 · Cited by 593
RetractedA Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
Potti, A., Mukherjee, S., Petersen, R., Dressman, H. K., Bild, A., Koontz, J., Kratzke, R., Watson, M. A., Kelley, M., Ginsburg, G. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060467 · Cited by 576
RetractedLynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527
Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
EGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,058
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
Tsao, M.-S., Sakurada, A., Cutz, J.-C., Zhu, C.-Q., Kamel-Reid, S., Squire, J., Lorimer, I., Zhang, T., Liu, N., Daneshmand, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050736 · Cited by 1,830
DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., André, F., Haddad, V., Taranchon, E., Filipits, M., Pirker, R., Popper, H. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060570 · Cited by 1,727
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Lung cancer in never smokers — a different disease
Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2190 · Cited by 1,608
Bean, J., Brennan, C., Shih, J.-Y., Riely, G., Viale, A., Wang, L., Chitale, D., Motoi, N., Szoke, J., Broderick, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710370104 · Cited by 1,598
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
Pao, W., Wang, T. Y., Riely, G. J., Miller, V. A., Pan, Q., Ladanyi, M., Zakowski, M. F., Heelan, R. T., Kris, M. G., & Varmus, H. E. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020017 · Cited by 1,516
Eberhard, D. A., Johnson, B. E., Amler, L. C., Goddard, A. D., Heldens, S. L., Herbst, R. S., Ince, W. L., Jänne, P. A., Januario, T., Johnson, D. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.857 · Cited by 1,461
Self-citationAmos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.109 · Cited by 1,310
Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275
Kim, E. S., Hirsh, V., Mok, T., Socinski, M. A., Gervais, R., Wu, Y.-L., Li, L.-Y., Watkins, C. L., Sellers, M. V., Lowe, E. S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61758-4 · Cited by 1,242
Self-citationDirector's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma (2008) · Nature Medicine · doi:10.1038/nm.1790 · Cited by 1,190
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179
Characterizing the cancer genome in lung adenocarcinoma
Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W. M., Province, M. A., Kraja, A., Johnson, L. A., et al. (2007) · Nature · doi:10.1038/nature06358 · Cited by 1,105
LKB1 modulates lung cancer differentiation and metastasis
Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., et al. (2007) · Nature · doi:10.1038/nature06030 · Cited by 1,064
BRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
Kwak, E. L., Sordella, R., Bell, D. W., Godin-Heymann, N., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Driscoll, D. R., Fidias, P., Lynch, T. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502860102 · Cited by 952
A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer
Chen, H.-Y., Yu, S.-L., Chen, C.-H., Chang, G.-C., Chen, C.-Y., Yuan, A., Cheng, C.-L., Wang, C.-H., Terng, H.-J., Kao, S.-F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060096 · Cited by 935
MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
Yu, S.-L., Chen, H.-Y., Chang, G.-C., Chen, C.-Y., Chen, H.-W., Singh, S., Cheng, C.-L., Yu, C.-J., Lee, Y.-C., Chen, H.-S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.008 · Cited by 783
Genetic clonal diversity predicts progression to esophageal adenocarcinoma
Maley, C. C., Galipeau, P. C., Finley, J. C., Wongsurawat, V. J., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., Risques, R.-A., Rabinovitch, P. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1768 · Cited by 696
Somatic Mutations of the HER2 Kinase Domain in Lung Adenocarcinomas
Shigematsu, H., Takahashi, T., Nomura, M., Majmudar, K., Suzuki, M., Lee, H., Wistuba, I. I., Fong, K. M., Toyooka, S., Shimizu, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4235 · Cited by 678
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
Greulich, H., Chen, T.-H., Feng, W., Jänne, P. A., Alvarez, J. V., Zappaterra, M., Bulmer, S. E., Frank, D. A., Hahn, W. C., Sellers, W. R., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020313 · Cited by 677
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Qi Chen, X., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647
Sequist, L. V., Bell, D. W., Lynch, T. J., & Haber, D. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3585 · Cited by 624
Effects of cigarette smoke on the human airway epithelial cell transcriptome
Spira, A., Beane, J., Shah, V., Liu, G., Schembri, F., Yang, X., Palma, J., & Brody, J. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401422101 · Cited by 619
DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
Brock, M. V., Hooker, C. M., Ota-Machida, E., Han, Y., Guo, M., Ames, S., Glöckner, S., Piantadosi, S., Gabrielson, E., Pridham, G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706550 · Cited by 593
Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
Riely, G. J., Kris, M. G., Rosenbaum, D., Marks, J., Li, A., Chitale, D. A., Nafa, K., Riedel, E. R., Hsu, M., Pao, W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0646 · Cited by 578
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer
Spira, A., Beane, J. E., Shah, V., Steiling, K., Liu, G., Schembri, F., Gilman, S., Dumas, Y.-M., Calner, P., Sebastiani, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1556 · Cited by 572
Cappuzzo, F., Marchetti, A., Skokan, M., Rossi, E., Gajapathy, S., Felicioni, L., del Grammastro, M., Sciarrotta, M. G., Buttitta, F., Incarbone, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1635 · Cited by 557
Bell, D. W., Gore, I., Okimoto, R. A., Godin-Heymann, N., Sordella, R., Mulloy, R., Sharma, S. V., Brannigan, B. W., Mohapatra, G., Settleman, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1671 · Cited by 531
Ma, P. C., Kijima, T., Maulik, G., Fox, E. A., Sattler, M., Griffin, J. D., Johnson, B. E., & Salgia, R. (2003) · PubMed · Cited by 516
Signaling networks assembled by oncogenic EGFR and c-Met
Guo, A., Villén, J., Kornhauser, J., Lee, K. A., Stokes, M. P., Rikova, K., Possemato, A., Nardone, J., Innocenti, G., Wetzel, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707270105 · Cited by 505
Yauch, R. L., Januario, T., Eberhard, D. A., Cavet, G., Zhu, W., Fu, L., Pham, T. Q., Soriano, R., Stinson, J., Seshagiri, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1492 · Cited by 495
Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase Activity
Weihua, Z., Tsan, R., Huang, W.-C., Wu, Q., Chiu, C.-H., Fidler, I. J., & Hung, M.-C. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.015 · Cited by 490
Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
Kong-Beltran, M., Seshagiri, S., Zha, J., Zhu, W., Bhawe, K., Mendoza, N., Holcomb, T., Pujara, K., Stinson, J., Fu, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2749 · Cited by 490
Dankort, D., Filenova, E., Collado, M., Serrano, M., Jones, K., & McMahon, M. (2007) · Genes & Development · doi:10.1101/gad.1516407 · Cited by 481
Politi, K., Zakowski, M. F., Fan, P.-D., Schonfeld, E. A., Pao, W., & Varmus, H. E. (2006) · Genes & Development · doi:10.1101/gad.1417406 · Cited by 478
Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., Turley, H., Talks, K., Pezzella, F., Gatter, K. C., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2018 · Cited by 478
Wang, S. E., Narasanna, A., Perez-Torres, M., Xiang, B., Wu, F. Y., Yang, S., Carpenter, G., Gazdar, A. F., Muthuswamy, S. K., & Arteaga, C. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.023 · Cited by 470
DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung Cancer
Zheng, Z., Chen, T., Li, X., Haura, E., Sharma, A., & Bepler, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065411 · Cited by 462
Ji, H., Li, D., Chen, L., Shimamura, T., Kobayashi, S., McNamara, K., Mahmood, U., Mitchell, A., Sun, Y., Al-Hashem, R., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.022 · Cited by 462
Clonal Genetic Alterations in the Lungs of Current and Former Smokers
Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Broxson, A., Khuri, F. R., Hong, W. K., Lee, J. J., Yu, R., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.12.857 · Cited by 453
Self-citationInukai, M., Toyooka, S., Ito, S., Asano, H., Ichihara, S., Soh, J., Suehisa, H., Ouchida, M., Aoe, K., Aoe, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1951 · Cited by 452
Cobo, M., Isla, D., Massuti, B., Montes, A., Sanchez, J. M., Provencio, M., Viñolas, N., Paz-Ares, L., Lopez-Vivanco, G., Muñoz, M. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7915 · Cited by 443
PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
Yamamoto, H., Shigematsu, H., Nomura, M., Lockwood, W. W., Sato, M., Okumura, N., Soh, J., Suzuki, M., Wistuba, I. I., Fong, K. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5084 · Cited by 429
Herbst, R. S., O'Neill, V. J., Fehrenbacher, L., Belani, C. P., Bonomi, P. D., Hart, L., Melnyk, O., Ramies, D., Lin, M., & Sandler, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3026 · Cited by 396
Self-citationBelinsky, S. A., Liechty, K. C., Gentry, F. D., Wolf, H. J., Rogers, J., Vu, K., Haney, J., Kennedy, T. C., Hirsch, F. R., Miller, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3408 · Cited by 389
Cappuzzo, F., Varella-Garcia, M., Shigematsu, H., Domenichini, I., Bartolini, S., Ceresoli, G. L., Rossi, E., Ludovini, V., Gregorc, V., Toschi, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.111 · Cited by 369
Genetic susceptibility to lung cancer: the role of DNA damage and repair.
Spitz, M. R., Wei, Q., Dong, Q., Amos, C. I., & Wu, X. (2003) · PubMed · Cited by 343
Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.
Franklin, W. A., Gazdar, A. F., Haney, J., Wistuba, I. I., La Rosa, F. G., Kennedy, T., Ritchey, D. M., & Miller, Y. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119748 · Cited by 330
A Major Lung Cancer Susceptibility Locus Maps to Chromosome 6q23–25
Bailey-Wilson, J. E., Amos, C. I., Pinney, S. M., Petersen, G. M., de Andrade, M., Wiest, J. S., Fain, P., Schwartz, A. G., You, M., Franklin, W., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423857 · Cited by 316
Taguchi, F., Solomon, B., Gregorc, V., Roder, H., Gray, R., Kasahara, K., Nishio, M., Brahmer, J., Spreafico, A., Ludovini, V., et al. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk195 · Cited by 312
A Translational View of the Molecular Pathogenesis of Lung Cancer
Sato, M., Shames, D. S., Gazdar, A. F., & Minna, J. D. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000263718.69320.4c · Cited by 297
Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.
Belinsky, S. A., Klinge, D. M., Stidley, C. A., Issa, J. J., Herman, J. G., March, T. H., & Baylin, S. B. (2003) · PubMed · Cited by 293
Heymach, J. V., Johnson, B. E., Prager, D., Csada, E., Roubec, J., Pešek, M., Špásová, I., Belani, C. P., Bodrogi, I., Gadgeel, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5122 · Cited by 293
Self-citationPrevalence and specificity of LKB1 genetic alterations in lung cancers
Matsumoto, S., Iwakawa, R., Takahashi, K., Kohno, T., Nakanishi, Y., Matsuno, Y., Suzuki, K., Nakamoto, M., Shimizu, E., Minna, J. D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210418 · Cited by 280
Gautschi, O., Bigosch, C., Huegli, B., Jermann, M., Marx, A., Chassé, E., Ratschiller, D., Weder, W., Joerger, M., Betticher, D. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.123 · Cited by 275
Hirsch, F. R., Herbst, R. S., Olsen, C., Chansky, K., Crowley, J., Kelly, K., Franklin, W. A., Bunn, P. A., Varella-Garcia, M., & Gandara, D. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.0111 · Cited by 271
Self-citationPore, N., Jiang, Z., Gupta, A., Cerniglia, G., Kao, G. D., & Maity, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3090 · Cited by 268
Tang, X., Shigematsu, H., Bekele, B. N., Roth, J. A., Minna, J. D., Hong, W. K., Gazdar, A. F., & Wistuba, I. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1705 · Cited by 266
Dowlati, A., Gray, R., Sandler, A. B., Schiller, J. H., & Johnson, D. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1154 · Cited by 263
Ji, H., Zhao, X., Yuza, Y., Shimamura, T., Li, D., Protopopov, A., Jung, B. L., McNamara, K., Xia, H., Glatt, K. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510284103 · Cited by 257
Morgillo, F., Kim, W.-Y., Kim, E. S., Ciardiello, F., Hong, W. K., & Lee, H.-Y. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2077 · Cited by 251
Panel of Serum Biomarkers for the Diagnosis of Lung Cancer
Patz, E. F., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., & Herndon, J. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5392 · Cited by 247
Weiss, G. J., Bemis, L. T., Nakajima, E., Sugita, M., Birks, D. K., Robinson, W. A., Varella-Garcia, M., Bunn, P. A., Haney, J., Helfrich, B. A., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn006 · Cited by 244
Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer
Kendall, J., Liu, Q., Bakleh, A., Krasnitz, A., Nguyen, K. C. Q., Lakshmi, B., Gerald, W. L., Powers, S., & Mu, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708286104 · Cited by 236
Heymach, J. V., Paz-Ares, L., De Braud, F., Sebastian, M., Stewart, D. J., Eberhardt, W. E. E., Ranade, A. A., Cohen, G., Trigo, J. M., Sandler, A. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3138 · Cited by 222
Self-citationLam, D. C.-L., Girard, L., Ramirez, R., Chau, W.-S., Suen, W.-S., Sheridan, S., Tin, V. P. C., Chung, L.-P., Wong, M. P., Shay, J. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4628 · Cited by 221
Zhou, X., Liu, S., Kim, E. S., Herbst, R. S., & Lee, J. J. (2008) · Clinical Trials · doi:10.1177/1740774508091815 · Cited by 206
Self-citationBeau-Faller, M., Ruppert, A.-M., Voegeli, A.-C., Neuville, A., Meyer, N., Guerin, E., Legrain, M., Mennecier, B., Wihlm, J.-M., Massard, G., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318168d9d4 · Cited by 201
Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.
Keith, R. L., Miller, Y. E., Gemmill, R. M., Drabkin, H. A., Dempsey, E. C., Kennedy, T. C., Prindiville, S. A., & Franklin, W. A. (2000) · PubMed · Cited by 199
Simon, G., Sharma, A., Li, X., Hazelton, T., Walsh, F., Williams, C., Chiappori, A., Haura, E., Tanvetyanon, T., Antonia, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2099 · Cited by 179
Promoter Hypermethylation of Resected Bronchial Margins
Guo, M., House, M. G., Hooker, C. M., Han, Y. K., Heath, E., Gabrielson, E. W., Yang, S. C., Baylin, S. B., Herman, J. G., & Brock, M. V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0763 · Cited by 173
Yanagi, S., Kishimoto, H., Kawahara, K., Sasaki, T., Sasaki, M., Nishio, M., Yajima, N., Hamada, K., Horie, Y., Kubo, H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31854 · Cited by 169
Godin-Heymann, N., Bryant, I., Rivera, M. N., Ulkus, L., Bell, D. W., Riese, D. J., Settleman, J. E., & Haber, D. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4625 · Cited by 165
Koivunen, J. P., Kim, J., Lee, J., Rogers, A. M., Park, J. O., Zhao, X., Naoki, K., Okamoto, I., Nakagawa, K., Yeap, B. Y., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604469 · Cited by 163
Smoking molecular damage in bronchial epithelium
Wistuba, I. I., Mao, L., & Gazdar, A. F. (2002) · Oncogene · doi:10.1038/sj.onc.1205806 · Cited by 157
Wislez, M., Spencer, L., Izzo, J. G., Juroske, D. M., Balhara, K. S., CODY, D. D., Price, R. E., Hittelman, W. N., Wistuba, I. I., & Kurie, J. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4420 · Cited by 152
Multiple Clonal Abnormalities in the Bronchial Epithelium of Patients With Lung Cancer
Park, I., Wistuba, I. I., Maitra, A., Milchgrub, S., Virmani, A. K., Minna, J. D., & Gazdar, A. F. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1863 · Cited by 150
Seike, M., Yanaihara, N., Bowman, E. D., Zanetti, K. A., Budhu, A., Kumamoto, K., Mechanic, L. E., Matsumoto, S., Yokota, J., Shibata, T., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm083 · Cited by 148
Molecular changes in the bronchial epithelium of patients with small cell lung cancer.
Wistuba, I. I., Berry, J., Behrens, C., Maitra, A., Shivapurkar, N., Milchgrub, S., Mackay, B., Minna, J. D., & Gazdar, A. F. (2000) · PubMed · Cited by 148
Non-ocular cancer in relatives of retinoblastoma patients
Sanders, B. M., Jay, M., Draper, G. J., & Roberts, E. P. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.285 · Cited by 134
West, K. A., Linnoila, I. R., Belinsky, S. A., Harris, C. C., & Dennis, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3241 · Cited by 133
Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung
Licchesi, J. D. F., Westra, W. H., Hooker, C. M., & Herman, J. G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2033 · Cited by 133
Somatic mutations of theERBB4kinase domain in human cancers
Soung, Y. H., Lee, J. W., Kim, S. Y., Wang, Y. P., Jo, K. H., Moon, S. W., Park, W. S., Nam, S. W., Lee, J. Y., Yoo, N. J., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21507 · Cited by 129
Ramírez, J. L., Rosell, R., Tarón, M., Sanchez-Ronco, M., Alberola, V., Peñas, R. D. L., Sánchez, J. M., Morán, T., Camps, C., Massutí, B., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2905 · Cited by 122
VEGF Polymorphisms and Survival in Early-Stage Non–Small-Cell Lung Cancer
Heist, R. S., Zhai, R., Liu, G., Zhou, W., Lin, X., Li, S., Asomaning, K., Lynch, T. J., Wain, J. C., & Christiani, D. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5947 · Cited by 119
Li, C., Lozano, G., Amos, C. I., Gu, X., Strong, L. C., & Hwang, S. (2003) · Human Genetics · doi:10.1007/s00439-003-0968-7 · Cited by 115
Diagnostic Accuracy of MALDI Mass Spectrometric Analysis of Unfractionated Serum in Lung Cancer
Yildiz, P. B., Shyr, Y., Rahman, J. S. M., Wardwell, N. R., Zimmerman, L. J., Shakhtour, B., Gray, W. H., Chen, S., Li, M., Röder, H., et al. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31814b8be7 · Cited by 115
Liu, G., Gurubhagavatula, S., Zhou, W., Wang, Z., Yeap, B. Y., Asomaning, K., Su, L., Heist, R. S., Lynch, T. J., & Christiani, D. C. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500444 · Cited by 114
Pirker, R., Ramlau, R., Schuette, W., Zatloukal, P., Ferreira, I., Lillie, T., & Vansteenkiste, J. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0748 · Cited by 114
EGFR-T790M Is a Rare Lung Cancer Susceptibility Allele with Enhanced Kinase Activity
Vikis, H. G., Sato, M., James, M. A., Wang, D., Wang, Y., Wang, M., Jia, D., Liu, Y., Wilson, J., Amos, C. I., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0217 · Cited by 113
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
Belinsky, S. A., Grimes, M. J., Casas, E., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603721 · Cited by 103
Zhang, S., Schafer-Hales, K. J., Khuri, F. R., Zhou, W., Vertino, P. M., & Marcus, A. I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2989 · Cited by 99
Tang, X., Varella‐Garcia, M., Xavier, A. C., Massarelli, E., Ozburn, N. C., Moran, C. A., & Wistuba, I. I. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0032 · Cited by 99
A Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features
Beane, J., Sebastiani, P., Whitfield, T. H., Steiling, K. A., Dumas, Y.-M., Lenburg, M. E., & Spira, A. E. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0011 · Cited by 99
Hypermethylation of ASC/TMS1 Is a Sputum Marker for Late-Stage Lung Cancer
Machida, E. O., Brock, M. V., Hooker, C. M., Nakayama, J., Ishida, A., Amano, J., Picchi, M. A., Belinsky, S. A., Herman, J. G., Taniguchi, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4447 · Cited by 95
The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments
Hoogsteen, I. J., Marres, H. A. M., van der Kogel, A. J., & Kaanders, J. H. A. M. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.03.001 · Cited by 90
Meyerson, M. M., & Carbone, D. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.15.511 · Cited by 89
Bhutani, M., Pathak, A., Fan, Y.-H., Liu, D. D., Lee, J. J., Tang, H., Kurie, J. M., Morice, R. C., Kim, E. S., Hong, W. K., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0058 · Cited by 86
Kim, J. S., Kim, J. W., Han, J., Shim, Y. M., Park, J., & Kim, D.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3813 · Cited by 84
Yang, Y., Iwanaga, K., Raso, M. G., Wislez, M., Hanna, A. E., Wieder, E., Molldrem, J. J., Wistuba, I. I., Powis, G., DeMayo, F. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002220 · Cited by 79
Ludovini, V., Pistola, L., Gregorc, V., Floriani, I., Rulli, E., Piattoni, S., Carlo, L. D., Semeraro, A., Darwish, S., Tofanetti, F. R., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318168c7d0 · Cited by 75
Yu, D., Zhang, X., Liu, J., Yuan, P., Tan, W., Guo, Y., Sun, T., Zhao, D., Yang, M., Liu, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1612 · Cited by 75
A 25-Signal Proteomic Signature and Outcome for Patients With Resected Non–Small-Cell Lung Cancer
Yanagisawa, K., Tomida, S., Shimada, Y., Yatabe, Y., Mitsudomi, T., & Takahashi, T. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk197 · Cited by 73
Molecular Signatures of Lung Cancer — Toward Personalized Therapy
Herbst, R. S., & Lippman, S. M. (2007) · New England Journal of Medicine · doi:10.1056/nejme068218 · Cited by 70
Self-citationBianchi, F., Hu, J., Pelosi, G., Cirincione, R., Ferguson, M. L., Ratcliffe, C., Fiore, P. P. D., Gatter, K. C., Pezzella, F., & Pastorino, U. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0619 · Cited by 70
Yang, Y., Wislez, M., Fujimoto, N., Prudkin, L., Izzo, J. G., Uno, F., Ji, L., Hanna, A. E., Langley, R. R., Liu, D., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2045 · Cited by 58
Germline Polymorphisms in EGFR and Survival in Patients With Lung Cancer Receiving Gefitinib
Gregorc, V., Hidalgo, M. M., Spreafico, A., Cusatis, G., Ludovini, V., Ingersoll, R., Marsh, S. A., Steinberg, S. M., Mg, V., Ghio, D., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100320 · Cited by 56
LKB1 and Lung Cancer: More Than the Usual Suspects
Shah, U., Sharpless, N. E., & Hayes, D. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6620 · Cited by 52
ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas
Jeong, E. G., Soung, Y. H., Lee, J. W., Lee, S. H., Nam, S. W., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22257 · Cited by 38
Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung
Sakuma, Y., Matsukuma, S., Yoshihara, M., Nakamura, Y., Nakayama, H., Kameda, Y., Tsuchiya, E., & Miyagi, Y. (2007) · Modern Pathology · doi:10.1038/modpathol.3800929 · Cited by 33
Out of the Shadows: CXC Chemokines in Promoting Aberrant Lung Cancer Angiogenesis
Strieter, R. M. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0168 · Cited by 10
(2001) · PubMed
Cited by
The biology and management of non-small cell lung cancer
Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891
Self-citationMitsudomi, T., Morita, S., Yatabe, Y., Negoro, S., Okamoto, I., Tsurutani, J., Seto, T., Satouchi, M., Tada, H., Hirashima, T., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70364-x · Cited by 4,090
Lung Cancer: Epidemiology, Etiology, and Prevention
Dela Cruz, C. S., Tanoue, L. T., & Matthay, R. A. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.09.001 · Cited by 2,484
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.014 · Cited by 2,001
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
Guo, X., Zhang, Y., Zheng, L., Zheng, C., Song, J., Zhang, Q., Kang, B., Liu, Z., Jin, L., Xing, R., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0045-3 · Cited by 1,651
Metadata
- Authors
- Herbst, R. S., Heymach, J. V., & Lippman, S. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-09-25
- Volume
- 359
- Issue
- 13
- Pages
- 1367-1380
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2566863750
- Cited by
- 2,389
- References
- 130
- FWCI
- 79.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.